Not many years ago, the idea of defeating the resilient virus that causes AIDS was far-fetched. But as 18,000 people gather this coming week in Durban, South Africa, for the 21st International AIDS Conference, the prospect of a cure is plausible enough that it is attracting increasing amounts of money, scientific research and attention. Also scheduled for this fall is a large-scale clinical trial of an HIV vaccine, which will be conducted in South Africa and co-funded by NIH.
Read Full Article »
